Novartis India has approved transfer of its over-the-counter division (OTC) division to GlaxoSmithKline Consumer (GSK CPL), for Rs1.97bn ($17.6m).
GSK CPL is a consumer healthcare joint venture (JV) between Swiss pharmaceutical firm Novartis and GSK.
Go deeper with GlobalData
The move is in line with the deal signed in April 2014, under which Novartis agreed with GSK to establish a global consumer healthcare JV, as part of its global portfolio transformation.
GSK will own 63.5% equity interest in the new JV, while Novartis will hold the remaining 36.5% stake.
Under the statement in a stock exchange filing with Bombay Stock Exchange (BSE) India, the sale of Novartis’ OTC business in India follows the divestment of its global OTC business, including all of its major patents, trademarks and R&D assets.
See Also:
Transfer of the OTC business is subject to receipt of all applicable legal and regulatory approvals, consents, permissions and sanctions as may be necessary from concerned authorities, as well as closing of the global joint venture transaction.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataNovartis agreed to sell its vaccines business, excluding flu business, to GSK for $7.1bn, in a multi-layered deal signed in April 2014.
The deal includes acquisition of GSK’s oncology unit by Novartis for $14.5bn and up to $1.5bn contingent on a development milestone.
In India, GSK holds various subsidiaries, including Biddle Sawyer, GSK Asia, GSK Consumer Healthcare and GSK Pharmaceuticals, while Novartis operates through Novartis India, Novartis Healthcare, Sandoz Private and Chiron Behring Vaccine Private in the country.
Image: GlaxoSmithKline headquarters in Brentford, London, England. Photo: courtesy of Maxwell Hamilton.
